Abstract
Radiofrequency ablation (RFA) has become the first choice for treatment of dysplastic Barrett's. RFA is indicated for flat high-grade dysplasia and for eradication of residual Barrett's after endoscopic resection of any visible lesion containing high-grade dysplasia or an early mucosal cancer. RFA has a high success rate for eradication of dysplasia in 95% of patients. Eradication of intestinal metaplasia can be obtained in approximately 80% of patients. This article is part of an expert video encyclopedia.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
